These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27879658)

  • 21. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
    Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
    Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.
    Curtin K; Slattery ML; Ulrich CM; Bigler J; Levin TR; Wolff RK; Albertsen H; Potter JD; Samowitz WS
    Carcinogenesis; 2007 Aug; 28(8):1672-9. PubMed ID: 17449906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.
    Ogino S; Kawasaki T; Kirkner GJ; Loda M; Fuchs CS
    J Mol Diagn; 2006 Nov; 8(5):582-8. PubMed ID: 17065427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
    Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
    Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG Island Methylator Phenotype-A Hope for the Future or a Road to Nowhere?
    Paweł K; Maria Małgorzata S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.
    Ogino S; Kawasaki T; Kirkner GJ; Suemoto Y; Meyerhardt JA; Fuchs CS
    Gut; 2007 Nov; 56(11):1564-71. PubMed ID: 17339237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer.
    Jo P; Jung K; Grade M; Conradi LC; Wolff HA; Kitz J; Becker H; Rüschoff J; Hartmann A; Beissbarth T; Müller-Dornieden A; Ghadimi M; Schneider-Stock R; Gaedcke J
    Surgery; 2012 Apr; 151(4):564-70. PubMed ID: 22001634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Slattery ML; Curtin K; Sweeney C; Levin TR; Potter J; Wolff RK; Albertsen H; Samowitz WS
    Int J Cancer; 2007 Feb; 120(3):656-63. PubMed ID: 17096326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly variant DNA methylation in normal tissues identifies a distinct subclass of cancer patients.
    Ghosh J; Schultz B; Coutifaris C; Sapienza C
    Adv Cancer Res; 2019; 142():1-22. PubMed ID: 30885359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer.
    Frazier ML; Xi L; Zong J; Viscofsky N; Rashid A; Wu EF; Lynch PM; Amos CI; Issa JP
    Cancer Res; 2003 Aug; 63(16):4805-8. PubMed ID: 12941799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status and significance of CpG island methylator phenotype in endometrial cancer.
    Zhang QY; Yi DQ; Zhou L; Zhang DH; Zhou TM
    Gynecol Obstet Invest; 2011; 72(3):183-91. PubMed ID: 21968189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma.
    Koh YW; Chun SM; Park YS; Song JS; Lee GK; Khang SK; Jang SJ
    Tumour Biol; 2016 Aug; 37(8):10675-84. PubMed ID: 26867769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas.
    Arai E; Gotoh M; Tian Y; Sakamoto H; Ono M; Matsuda A; Takahashi Y; Miyata S; Totsuka H; Chiku S; Komiyama M; Fujimoto H; Matsumoto K; Yamada T; Yoshida T; Kanai Y
    Int J Cancer; 2015 Dec; 137(11):2589-606. PubMed ID: 26061684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.
    Weisenberger DJ; Levine AJ; Long TI; Buchanan DD; Walters R; Clendenning M; Rosty C; Joshi AD; Stern MC; LeMarchand L; Lindor NM; Daftary D; Gallinger S; Selander T; Bapat B; Newcomb PA; Campbell PT; Casey G; Ahnen DJ; Baron JA; Haile RW; Hopper JL; Young JP; Laird PW; Siegmund KD;
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):512-519. PubMed ID: 25587051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
    Court F; Arnaud P
    Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
    Ogino S; Kawasaki T; Ogawa A; Kirkner GJ; Loda M; Fuchs CS
    Hum Pathol; 2007 Apr; 38(4):614-20. PubMed ID: 17270239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors.
    Marsit CJ; Houseman EA; Christensen BC; Eddy K; Bueno R; Sugarbaker DJ; Nelson HH; Karagas MR; Kelsey KT
    Cancer Res; 2006 Nov; 66(21):10621-9. PubMed ID: 17079487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
    Ogino S; Cantor M; Kawasaki T; Brahmandam M; Kirkner GJ; Weisenberger DJ; Campan M; Laird PW; Loda M; Fuchs CS
    Gut; 2006 Jul; 55(7):1000-6. PubMed ID: 16407376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.